• 순천향대학교 의학과 박사 수료
• 울산대학교 의학과 석사
• 순천향대학교 의학과 졸업

• 현재  | 이대목동병원 영상의학과 임상교수
• 2025-2026  | 삼성서울병원 영상의학과 교수
• 2019-2025  | 삼성서울병원 영상의학과 부교수
• 2017-2019  | 삼성서울병원 영상의학과 조교수
• 2015-2017  | 삼성서울병원 영상의학과 인터벤션 진료조교수
• 2014-2015  | 삼성서울병원 영상의학과 인터벤션 임상전임강사
• 2012-2014  | 삼성서울병원 영상의학과 인터벤션 전임의
• 2011-2012  | 오산한국병원 영상의학과 과장
• 2007-2011  | 서울아산병원 영상의학과 전공의

• 2025 | 대한간암학회정기학술대회 우수구연상
• 2015 | 대한인터벤션영상의학회 젊은의학자상

• 2023-2024  | 대한인터벤션 영상의학과 학술이사
• 2021-2022  | 대한인터벤션 영상의학과 재무이사

•  Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection.  J Korean Soc Radiol. 2025-07. 
•  Role of Lymphatic Embolization in Chylothorax Associated with Gorham-Stout Disease: A Case Report.  J Korean Soc Radiol. 2024-03. 
•  Recanalization of Portal Vein Graft Occlusion via a Percutaneous Transmesenteric Approach: A Case Report.  J Korean Soc Radiol. 2024-01. 
•  Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes.  Cancers (Basel). 2023-10. 
•  Factors Contributing to Successful Transvenous Retrograde Thoracic Duct Cannulation.  J Vasc Interv Radiol. 2023-02. 
•  Modified Surgical Drain-Guided Percutaneous Catheter Drainage of Postoperative Fluid Collection in Inaccessible Locations.  J Vasc Interv Radiol. 2022-12. 
•  Pragmatic role of noncontrast magnetic resonance lymphangiography in postoperative chylothorax or cervical chylous leakage as a diagnostic and preprocedural planning tool.  Eur Radiol. 2022-04. 
•  CT findings after left renal vein division during abdominal aortic surgery.  Acta Radiol. 2021-12. 
•  Ultrasound-Guided Deployment of a Plug-Based Vascular Closure Device in Femoral Arteries with Calcified Plaque or Stenosis.  J Vasc Interv Radiol. 2021-06. 
•  Management of chyle leakage after general thoracic surgery: Impact of thoracic duct embolization.  Thorac Cancer. 2021-05. 
•  Selective Versus Non-selective Transarterial Chemoembolization via the Intercostal Artery for the Treatment of Hepatocellular Carcinoma.  Cardiovasc Intervent Radiol. 2020-04. 
•  Soft-Tissue Tumors Mimicking Arteriovenous Malformations.  J Vasc Interv Radiol. 2019-10. 
•  The Role of TARE for Bridging and Downstaging of HCC Before Resection or Liver Transplant.  Cancers (Basel). 2026-01. 
•  Risk-based selection of treatment strategies in hepatocellular carcinoma with macrovascular invasion.  Radiother Oncol. 2026-01. 
•  Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.  Diagn Interv Imaging. 2026-01. 
•  Application of LI-RADS CT/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma.  Jpn J Radiol. 2025-09. 
•  Comparison between Onyx and coil embolization for persistent type 2 endoleaks after endovascular aneurysm repair.  Ann Surg Treat Res. 2024-03. 
•  External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion.  Radiother Oncol. 2023-10. 
•  Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.  Clin Mol Hepatol. 2023-07. 
•  Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery.  J Vasc Interv Radiol. 2023-01. 
•  Risk factors for stent occlusion after catheter-directed thrombolysis and iliac vein stenting in the treatment of May-Thurner syndrome with iliofemoral deep vein thrombosis: a retrospective cohort study.  Quant Imaging Med Surg. 2022-12. 
•  Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.  J Nucl Med. 2022-08. 
•  Optimal timing of portal vein embolization (PVE) after preoperative biliary drainage for hilar cholangiocarcinoma.  HPB (Oxford). 2022-05. 
•  Combined transarterial chemoembolization and radiofrequency ablation for subphrenic versus nonsubphrenic hepatocellular carcinoma: a propensity score matched study.  Abdom Radiol (NY). 2021-12. 
•  Guidewire-catheter induced hydrodissection to assist radiofrequency ablation for subcapsular hepatocellular carcinoma with iodized oil retention in patients with failed artificial ascites due to perihepatic adhesion.  Diagn Interv Radiol. 2021-11. 
•  Long term clinical outcomes of portal vein stenting for symptomatic portal vein stenosis after pancreaticoduodenectomy.  Medicine (Baltimore). 2021-10. 
•  Radiologic and clinical results of transarterial ethanol embolization for renal angiomyolipoma.  Eur Radiol. 2021-09. 
•  Therapeutic outcomes of embolotherapy of extremity bone intraosseous arteriovenous malformation with ethanol, coils, and n-butyl cyanoacrylate.  J Vasc Surg. 2021-06. 
•  Combined therapy with bronchial artery embolization and tranexamic acid for hemoptysis.  Acta Radiol. 2021-05. 
•  Rectus Sheath Hematoma Associated with the Mynx Vascular Closure Device.  J Vasc Interv Radiol. 2021-03. 
•  Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling.  Ther Adv Endocrinol Metab. 2021-02. 
•  Reversed Approach through Lymphocele/Lymphatic Fluid Collection for Glue Embolization of Injured Lymphatic Vessels.  J Vasc Interv Radiol. 2021-02. 
•  Impact of Superselective Renal Artery Embolization on Renal Function and Blood Pressure.  J Belg Soc Radiol. 2020-11. 
•  Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria.  Ann Surg Treat Res. 2020-10. 
•  Factors associated with the development of post-thrombotic syndrome in patients with iliofemoral deep venous thrombosis who underwent catheter-directed thrombolysis.  Phlebology. 2020-10. 
•  Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter.  Cancers (Basel). 2020-08. 
•  Clinical outcomes after internal iliac artery embolization prior to endovascular aortic aneurysm repair.  Int Angiol. 2020-08. 
•  Subclassification and Treatment Results of Ethanol Embolotherapy of Type II Arteriovenous Malformations of the Extremity and Body.  J Vasc Interv Radiol. 2019-09. 
•  Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy.  Abdom Radiol (NY). 2019-06. 
•  Endovascular treatment results and risk factors for complications of body and extremity arteriovenous malformations.  J Vasc Surg. 2019-04. 

• [헬스조선] 수술 어려운 간암 환자, ‘테라스피어’가 치료 선택지 넓혔다 2026-06-11